Krishna Rao, MD, MS

University of Michigan

Disclosure(s): Merck & Co., Inc.: Grant/Research Support; Seres Therapeutics: Advisor/Consultant; Summit Therapeutics: Advisor/Consultant

Poster(s):

• 274 - Epidemiology and Antimicrobial Treatment Impact of Procalcitonin in Patients with COVID-19
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET